ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer

I. Chow Joe Hsu, Yoshiya Yamada, Dean G. Assimos, Anthony V. D'Amico, Brian J. Davis, Steven J. Frank, Alexander R. Gottschalk, Gary S. Gustafson, Patrick W. McLaughlin, Paul L. Nguyen, Seth A. Rosenthal, Al V. Taira, Neha Vapiwala, Gregory Merrick

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: High-dose-rate (HDR) brachytherapy plays a potential curative role in the treatment of prostate cancer. An expert panel was convened to review the recent literature and reach a consensus on its appropriate clinical applications. Methods and Materials: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: A summary of HDR brachytherapy's clinical applications and recent literature review was completed. Three clinical variants were developed to address common HDR dose, fractionations, and indications for its use in definitive therapy for primary and local recurrent prostate cancer. The panel reached a consensus on the specific treatment approaches with numerical rating and commentary. Conclusions: In combining available medical literature and expert opinion, this manuscript may serve as an aid for other practitioners in the appropriate application of HDR brachytherapy for prostate cancer.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalBrachytherapy
Volume13
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Brachytherapy
Prostatic Neoplasms
Expert Testimony
Guidelines
Dose Fractionation
Therapeutics
Radiology

Keywords

  • Appropriateness criteria
  • Brachytherapy
  • HDR
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Hsu, I. C. J., Yamada, Y., Assimos, D. G., D'Amico, A. V., Davis, B. J., Frank, S. J., ... Merrick, G. (2014). ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy, 13(1), 27-31. https://doi.org/10.1016/j.brachy.2013.11.007

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. / Hsu, I. Chow Joe; Yamada, Yoshiya; Assimos, Dean G.; D'Amico, Anthony V.; Davis, Brian J.; Frank, Steven J.; Gottschalk, Alexander R.; Gustafson, Gary S.; McLaughlin, Patrick W.; Nguyen, Paul L.; Rosenthal, Seth A.; Taira, Al V.; Vapiwala, Neha; Merrick, Gregory.

In: Brachytherapy, Vol. 13, No. 1, 01.2014, p. 27-31.

Research output: Contribution to journalArticle

Hsu, ICJ, Yamada, Y, Assimos, DG, D'Amico, AV, Davis, BJ, Frank, SJ, Gottschalk, AR, Gustafson, GS, McLaughlin, PW, Nguyen, PL, Rosenthal, SA, Taira, AV, Vapiwala, N & Merrick, G 2014, 'ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer', Brachytherapy, vol. 13, no. 1, pp. 27-31. https://doi.org/10.1016/j.brachy.2013.11.007
Hsu ICJ, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ et al. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2014 Jan;13(1):27-31. https://doi.org/10.1016/j.brachy.2013.11.007
Hsu, I. Chow Joe ; Yamada, Yoshiya ; Assimos, Dean G. ; D'Amico, Anthony V. ; Davis, Brian J. ; Frank, Steven J. ; Gottschalk, Alexander R. ; Gustafson, Gary S. ; McLaughlin, Patrick W. ; Nguyen, Paul L. ; Rosenthal, Seth A. ; Taira, Al V. ; Vapiwala, Neha ; Merrick, Gregory. / ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. In: Brachytherapy. 2014 ; Vol. 13, No. 1. pp. 27-31.
@article{79a7a1052d8d4aaf84a6761fbb548eee,
title = "ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer",
abstract = "Purpose: High-dose-rate (HDR) brachytherapy plays a potential curative role in the treatment of prostate cancer. An expert panel was convened to review the recent literature and reach a consensus on its appropriate clinical applications. Methods and Materials: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: A summary of HDR brachytherapy's clinical applications and recent literature review was completed. Three clinical variants were developed to address common HDR dose, fractionations, and indications for its use in definitive therapy for primary and local recurrent prostate cancer. The panel reached a consensus on the specific treatment approaches with numerical rating and commentary. Conclusions: In combining available medical literature and expert opinion, this manuscript may serve as an aid for other practitioners in the appropriate application of HDR brachytherapy for prostate cancer.",
keywords = "Appropriateness criteria, Brachytherapy, HDR, Prostate cancer",
author = "Hsu, {I. Chow Joe} and Yoshiya Yamada and Assimos, {Dean G.} and D'Amico, {Anthony V.} and Davis, {Brian J.} and Frank, {Steven J.} and Gottschalk, {Alexander R.} and Gustafson, {Gary S.} and McLaughlin, {Patrick W.} and Nguyen, {Paul L.} and Rosenthal, {Seth A.} and Taira, {Al V.} and Neha Vapiwala and Gregory Merrick",
year = "2014",
month = "1",
doi = "10.1016/j.brachy.2013.11.007",
language = "English (US)",
volume = "13",
pages = "27--31",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer

AU - Hsu, I. Chow Joe

AU - Yamada, Yoshiya

AU - Assimos, Dean G.

AU - D'Amico, Anthony V.

AU - Davis, Brian J.

AU - Frank, Steven J.

AU - Gottschalk, Alexander R.

AU - Gustafson, Gary S.

AU - McLaughlin, Patrick W.

AU - Nguyen, Paul L.

AU - Rosenthal, Seth A.

AU - Taira, Al V.

AU - Vapiwala, Neha

AU - Merrick, Gregory

PY - 2014/1

Y1 - 2014/1

N2 - Purpose: High-dose-rate (HDR) brachytherapy plays a potential curative role in the treatment of prostate cancer. An expert panel was convened to review the recent literature and reach a consensus on its appropriate clinical applications. Methods and Materials: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: A summary of HDR brachytherapy's clinical applications and recent literature review was completed. Three clinical variants were developed to address common HDR dose, fractionations, and indications for its use in definitive therapy for primary and local recurrent prostate cancer. The panel reached a consensus on the specific treatment approaches with numerical rating and commentary. Conclusions: In combining available medical literature and expert opinion, this manuscript may serve as an aid for other practitioners in the appropriate application of HDR brachytherapy for prostate cancer.

AB - Purpose: High-dose-rate (HDR) brachytherapy plays a potential curative role in the treatment of prostate cancer. An expert panel was convened to review the recent literature and reach a consensus on its appropriate clinical applications. Methods and Materials: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: A summary of HDR brachytherapy's clinical applications and recent literature review was completed. Three clinical variants were developed to address common HDR dose, fractionations, and indications for its use in definitive therapy for primary and local recurrent prostate cancer. The panel reached a consensus on the specific treatment approaches with numerical rating and commentary. Conclusions: In combining available medical literature and expert opinion, this manuscript may serve as an aid for other practitioners in the appropriate application of HDR brachytherapy for prostate cancer.

KW - Appropriateness criteria

KW - Brachytherapy

KW - HDR

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84892507135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892507135&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2013.11.007

DO - 10.1016/j.brachy.2013.11.007

M3 - Article

C2 - 24368283

AN - SCOPUS:84892507135

VL - 13

SP - 27

EP - 31

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 1

ER -